A Study to Evaluate AI-09 In Participants With Glabellar Lines
Clinical trial NCT07321834 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07321834
- Sponsor
- Eirion Therapeutics Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-03
- Primary completion
- 2026-02-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.